Stay updated with breaking news from Emmaus Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emmaus Life Sciences, Inc. (OTCMKTS:EMMA – Get Free Report) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 800 shares, a decline of 89.5% from the March 15th total of 7,600 shares. Based on an average daily trading volume, of 12,400 shares, the […]
Premier database and directory of PR firms & public relations agencies. Find the firm that best suits your needs.
TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, today announced that it has received marketing authorization from the Puerto...
Emmaus Life Sciences, Inc. (OTCMKTS:EMMA – Get Free Report) saw a large drop in short interest in December. As of December 15th, there was short interest totalling 800 shares, a drop of 50.0% from the November 30th total of 1,600 shares. Based on an average daily trading volume, of 14,100 shares, the days-to-cover ratio is […]
Item1.01 Entry into a Material Definitive Agreement On December 15, 2023, Emmaus Life Sciences, Inc. entered into an Exchange Agreement with Wei Peu Zen and Seah Lim,...